Andrew Kenneth Lynn

Orthomimetics brings a new dimension to the treatment of joints damaged through sport or other orthopaedic trauma. Its heritage is a trans-Atlantic collaboration between two world-leading academic institutions, the University of Cambridge and the Massachusetts Institute of Technology (MIT), who have each contributed 30 years of experience to the repair of bone and soft tissues respectively. The harnessing of their expertise into viable therapeutic medical products is the foundation of Orthomimetics.

TiGenix NV engages in the research, development, and commercialization of biopharmaceutical products. The firm's portfolio includes allogeneic adipose-derived stem cells and allogeneic cardiac stem cells. It intends to treat Crohn's disease, sepsis, autoimmune disorders, acute myocardial infarction, and chronic cardiovascular indication. The company was founded by Gil Beyen and Frank P. Luyten on February 21, 2000 and is headquartered in Leuven, Belgium.

Fluidic Analytics Ltd. develops proprietary technology to characterize proteins. The company was founded by Tuomas Knowles in 2013 and is headquartered in Cambridge, the United Kingdom.

AtoCap Ltd. provides electro-hydrodynamic processing technology . The company was founded by Mohan Edirisinghe, William Bonfield and Eleanor Stride and is headquartered in London, the United Kingdom.

Paragraf Ltd. operates as a graphene technology development firm. Its products include graphene layers, heterostructures, thin film material heterostructures, and graphene devices as well as novel 2D materials. The company was founded on November 25, 2015 and is headquartered in , the Cambridgeshire,United Kingdom.